-
1
المؤلفون: Harman S. Sekhon, Glenwood D. Goss, Jim Dimitroulakos, Aisling A. Clancy, Johanna N. Spaans, Marc M. Duciaume, Bryan Lo, Johanne I. Weberpals
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::495d6e02e31a34b2df8b02063b1d404e
https://doi.org/10.1158/1078-0432.22467617 -
2
المؤلفون: Harman S. Sekhon, Glenwood D. Goss, Jim Dimitroulakos, Aisling A. Clancy, Johanna N. Spaans, Marc M. Duciaume, Bryan Lo, Johanne I. Weberpals
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f5a04c374e2c2b986222d854209afae
https://doi.org/10.1158/1078-0432.22467620.v1 -
3
المؤلفون: Harman S. Sekhon, Glenwood D. Goss, Jim Dimitroulakos, Aisling A. Clancy, Johanna N. Spaans, Marc M. Duciaume, Bryan Lo, Johanne I. Weberpals
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::375f464edfa74c40d79c70220e9e8be0
https://doi.org/10.1158/1078-0432.22467626.v1 -
4دورية أكاديمية
المؤلفون: Goss GD; The Ottawa Hospital Research Institute, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.; Division of Medical Oncology, Department of Medicine, The Ottawa Hospital Cancer Center and the University of Ottawa, ON K1N 6N5, Canada., Spaans JN; The Ottawa Hospital Research Institute, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada., Huntsman D; Imagia Canexia Health, Suite #204 Donald Rix Building, 2389 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada.; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC V6T 1Z4, Canada., Asmis T; Division of Medical Oncology, Department of Medicine, The Ottawa Hospital Cancer Center and the University of Ottawa, ON K1N 6N5, Canada., Andrews Wright NM; The Ottawa Hospital Research Institute, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada., Duciaume M; The Ottawa Hospital Research Institute, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada., Kaurah P; Imagia Canexia Health, Suite #204 Donald Rix Building, 2389 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada.; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, and Hereditary Cancer Program, BC Cancer, Vancouver, BC V5Z 4E6, Canada., Miller RR; Imagia Canexia Health, Suite #204 Donald Rix Building, 2389 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada., Banerji S; CancerCare Manitoba Research Institute, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R3E 0V9, Canada., Sekhon HS; The Ottawa Hospital Research Institute, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.; Department of Pathology, The Ottawa Hospital and the University of Ottawa, Ottawa, ON K1N 6N5, Canada., Gomes MM; The Ottawa Hospital Research Institute, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.; Department of Pathology, The Ottawa Hospital and the University of Ottawa, Ottawa, ON K1N 6N5, Canada.
المصدر: Current oncology (Toronto, Ont.) [Curr Oncol] 2022 Apr 29; Vol. 29 (5), pp. 3171-3186. Date of Electronic Publication: 2022 Apr 29.
نوع المنشور: Journal Article
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE
مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Squamous Cell* , Lung Neoplasms*/genetics, Aged ; Canada ; Female ; Humans ; Inuit ; Male ; Retrospective Studies
-
5دورية أكاديمية
المؤلفون: Weberpals JI; Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, ON, Canada.; Ottawa Hospital Research Institute, Ottawa, ON, Canada., Pugh TJ; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Ontario Institute for Cancer Research, Toronto, ON, Canada., Marco-Casanova P; Translational Medicine, R&D Oncology, AstraZeneca, Cambridge, UK., Goss GD; Ottawa Hospital Research Institute, Ottawa, ON, Canada.; Department of Medicine, Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada., Andrews Wright N; Ottawa Hospital Research Institute, Ottawa, ON, Canada., Rath P; Ontario Institute for Cancer Research, Toronto, ON, Canada., Torchia J; Ontario Institute for Cancer Research, Toronto, ON, Canada., Fortuna A; Ontario Institute for Cancer Research, Toronto, ON, Canada., Jones GN; Translational Medicine, R&D Oncology, AstraZeneca, Cambridge, UK., Roudier MP; Translational Medicine, R&D Oncology, AstraZeneca, Cambridge, UK., Bernard L; Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, ON, Canada.; Ottawa Hospital Research Institute, Ottawa, ON, Canada., Lo B; Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, ON, Canada., Torti D; Ontario Institute for Cancer Research, Toronto, ON, Canada., Leon A; Ontario Institute for Cancer Research, Toronto, ON, Canada., Marsh K; Ontario Institute for Cancer Research, Toronto, ON, Canada., Hodgson D; Translational Medicine, R&D Oncology, AstraZeneca, Cambridge, UK., Duciaume M; Ottawa Hospital Research Institute, Ottawa, ON, Canada., Howat WJ; Translational Medicine, R&D Oncology, AstraZeneca, Cambridge, UK., Lukashchuk N; Translational Medicine, R&D Oncology, AstraZeneca, Cambridge, UK., Lazic SE; Quantitative Biology, IMED Biotech Unit, AstraZeneca, Cambridge, UK., Whelan D; Ottawa Hospital Research Institute, Ottawa, ON, Canada., Sekhon HS; Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, ON, Canada.; Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, ON, Canada.
المصدر: Cancer medicine [Cancer Med] 2021 May; Vol. 10 (9), pp. 3045-3058. Date of Electronic Publication: 2021 Apr 03.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE
مواضيع طبية MeSH: Cystadenocarcinoma, Serous/*genetics , Cystadenocarcinoma, Serous/*immunology , Ovarian Neoplasms/*genetics , Ovarian Neoplasms/*immunology , Transcriptome/*genetics, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Ataxia Telangiectasia Mutated Proteins/genetics ; B7-H1 Antigen/metabolism ; Carboplatin/administration & dosage ; Class I Phosphatidylinositol 3-Kinases/genetics ; Cystadenocarcinoma, Serous/drug therapy ; Cystadenocarcinoma, Serous/pathology ; Cytoreduction Surgical Procedures ; Female ; Gene Amplification ; Gene Expression Profiling ; Genes, BRCA1 ; Genes, BRCA2 ; Genes, p53 ; Humans ; MDS1 and EVI1 Complex Locus Protein/genetics ; Middle Aged ; Mutation ; Neoplasm Proteins/metabolism ; Nuclear Proteins/genetics ; Nuclear Proteins/metabolism ; Ovarian Neoplasms/drug therapy ; Ovarian Neoplasms/pathology ; Paclitaxel/administration & dosage ; Progression-Free Survival ; Repressor Proteins/metabolism ; Retrospective Studies ; Time Factors ; Treatment Outcome ; Exome Sequencing